Viral Molecular Mimicry Influences the Antitumor Immune Response in Murine and Human Melanoma
Jacopo Chiaro, Henna H. E. Kasanen, Thomas Whalley, Cristian Capasso, Mikaela Grönholm, Sara Feola, Karita D. Peltonen, Firas S. Hamdan, Micaela M. Hernberg, Siru Mäkelä, Hanna Karhapää, Paul E. Brown, Beatriz Martins, Manlio Fusciello, Erkko Ylösmäki, Anna S. Kreutzman, Satu M. Mustjoki, Barbara Szomolay, View ORCID ProfileVincenzo Cerullo
doi: https://doi.org/10.1101/2020.09.09.20191171
Jacopo Chiaro
1Laboratory of Immunovirotherapy, Drug Research Program, Faculty of Pharmacy, University of Helsinki, Viikinkaari 5E, 00790 Helsinki, Finland.
2TRIMM, Translational Immunology Research Program, University of Helsinki, Finland.
Henna H. E. Kasanen
2TRIMM, Translational Immunology Research Program, University of Helsinki, Finland.
3Hematology Research Unit Helsinki, Department of Hematology, University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Haartmaninkatu 8, 00290, Helsinki, Finland.
4Department of Clinical Chemistry, University of Helsinki, Helsinki, Finland.
Thomas Whalley
5Systems Immunity Research Institute, Cardiff University School of Medicine, Cardiff, United Kingdom.
Cristian Capasso
1Laboratory of Immunovirotherapy, Drug Research Program, Faculty of Pharmacy, University of Helsinki, Viikinkaari 5E, 00790 Helsinki, Finland.
2TRIMM, Translational Immunology Research Program, University of Helsinki, Finland.
Mikaela Grönholm
1Laboratory of Immunovirotherapy, Drug Research Program, Faculty of Pharmacy, University of Helsinki, Viikinkaari 5E, 00790 Helsinki, Finland.
2TRIMM, Translational Immunology Research Program, University of Helsinki, Finland.
Sara Feola
1Laboratory of Immunovirotherapy, Drug Research Program, Faculty of Pharmacy, University of Helsinki, Viikinkaari 5E, 00790 Helsinki, Finland.
2TRIMM, Translational Immunology Research Program, University of Helsinki, Finland.
Karita D. Peltonen
1Laboratory of Immunovirotherapy, Drug Research Program, Faculty of Pharmacy, University of Helsinki, Viikinkaari 5E, 00790 Helsinki, Finland.
2TRIMM, Translational Immunology Research Program, University of Helsinki, Finland.
Firas S. Hamdan
1Laboratory of Immunovirotherapy, Drug Research Program, Faculty of Pharmacy, University of Helsinki, Viikinkaari 5E, 00790 Helsinki, Finland.
2TRIMM, Translational Immunology Research Program, University of Helsinki, Finland.
Micaela M. Hernberg
2TRIMM, Translational Immunology Research Program, University of Helsinki, Finland.
6Department of Oncology, Comprehensive Cancer Center, Helsinki University Hospital and Helsinki University.
Siru Mäkelä
2TRIMM, Translational Immunology Research Program, University of Helsinki, Finland.
6Department of Oncology, Comprehensive Cancer Center, Helsinki University Hospital and Helsinki University.
Hanna Karhapää
2TRIMM, Translational Immunology Research Program, University of Helsinki, Finland.
6Department of Oncology, Comprehensive Cancer Center, Helsinki University Hospital and Helsinki University.
Paul E. Brown
7Warwick Systems Biology Centre, University of Warwick.
Beatriz Martins
1Laboratory of Immunovirotherapy, Drug Research Program, Faculty of Pharmacy, University of Helsinki, Viikinkaari 5E, 00790 Helsinki, Finland.
2TRIMM, Translational Immunology Research Program, University of Helsinki, Finland.
Manlio Fusciello
1Laboratory of Immunovirotherapy, Drug Research Program, Faculty of Pharmacy, University of Helsinki, Viikinkaari 5E, 00790 Helsinki, Finland.
2TRIMM, Translational Immunology Research Program, University of Helsinki, Finland.
Erkko Ylösmäki
1Laboratory of Immunovirotherapy, Drug Research Program, Faculty of Pharmacy, University of Helsinki, Viikinkaari 5E, 00790 Helsinki, Finland.
2TRIMM, Translational Immunology Research Program, University of Helsinki, Finland.
Anna S. Kreutzman
1Laboratory of Immunovirotherapy, Drug Research Program, Faculty of Pharmacy, University of Helsinki, Viikinkaari 5E, 00790 Helsinki, Finland.
2TRIMM, Translational Immunology Research Program, University of Helsinki, Finland.
3Hematology Research Unit Helsinki, Department of Hematology, University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Haartmaninkatu 8, 00290, Helsinki, Finland.
4Department of Clinical Chemistry, University of Helsinki, Helsinki, Finland.
Satu M. Mustjoki
2TRIMM, Translational Immunology Research Program, University of Helsinki, Finland.
3Hematology Research Unit Helsinki, Department of Hematology, University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Haartmaninkatu 8, 00290, Helsinki, Finland.
4Department of Clinical Chemistry, University of Helsinki, Helsinki, Finland.
8iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki.
9HiLIFE Helsinki Institute of Life Science.
Barbara Szomolay
4Department of Clinical Chemistry, University of Helsinki, Helsinki, Finland.
Vincenzo Cerullo
1Laboratory of Immunovirotherapy, Drug Research Program, Faculty of Pharmacy, University of Helsinki, Viikinkaari 5E, 00790 Helsinki, Finland.
2TRIMM, Translational Immunology Research Program, University of Helsinki, Finland.
8iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki.
10Department of Molecular Medicine and Medical Biotechnology and CEINGE, Naples University Federico II, 80131, Naples, Italy.
Data Availability
All the data presented in this manuscript are available
Posted September 10, 2020.
Viral Molecular Mimicry Influences the Antitumor Immune Response in Murine and Human Melanoma
Jacopo Chiaro, Henna H. E. Kasanen, Thomas Whalley, Cristian Capasso, Mikaela Grönholm, Sara Feola, Karita D. Peltonen, Firas S. Hamdan, Micaela M. Hernberg, Siru Mäkelä, Hanna Karhapää, Paul E. Brown, Beatriz Martins, Manlio Fusciello, Erkko Ylösmäki, Anna S. Kreutzman, Satu M. Mustjoki, Barbara Szomolay, Vincenzo Cerullo
medRxiv 2020.09.09.20191171; doi: https://doi.org/10.1101/2020.09.09.20191171
Viral Molecular Mimicry Influences the Antitumor Immune Response in Murine and Human Melanoma
Jacopo Chiaro, Henna H. E. Kasanen, Thomas Whalley, Cristian Capasso, Mikaela Grönholm, Sara Feola, Karita D. Peltonen, Firas S. Hamdan, Micaela M. Hernberg, Siru Mäkelä, Hanna Karhapää, Paul E. Brown, Beatriz Martins, Manlio Fusciello, Erkko Ylösmäki, Anna S. Kreutzman, Satu M. Mustjoki, Barbara Szomolay, Vincenzo Cerullo
medRxiv 2020.09.09.20191171; doi: https://doi.org/10.1101/2020.09.09.20191171
Subject Area
Subject Areas
- Addiction Medicine (216)
- Allergy and Immunology (495)
- Anesthesia (106)
- Cardiovascular Medicine (1101)
- Dermatology (141)
- Emergency Medicine (274)
- Epidemiology (9782)
- Gastroenterology (481)
- Genetic and Genomic Medicine (2318)
- Geriatric Medicine (223)
- Health Economics (463)
- Health Informatics (1563)
- Health Policy (737)
- Hematology (238)
- HIV/AIDS (507)
- Medical Education (240)
- Medical Ethics (67)
- Nephrology (258)
- Neurology (2148)
- Nursing (134)
- Nutrition (338)
- Oncology (1183)
- Ophthalmology (366)
- Orthopedics (129)
- Otolaryngology (220)
- Pain Medicine (148)
- Palliative Medicine (50)
- Pathology (313)
- Pediatrics (698)
- Primary Care Research (267)
- Public and Global Health (4673)
- Radiology and Imaging (781)
- Respiratory Medicine (624)
- Rheumatology (274)
- Sports Medicine (210)
- Surgery (252)
- Toxicology (43)
- Transplantation (120)
- Urology (94)